Dr. Jasmin Javaherian , DO
Internal Medicine • Encino, CA
16661 Ventura Blvd Ste 815
Encino, CA 914361996
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Jasmin Javaherian is listed in NPPES under Internal Medicine.
-
NPI assigned on June 16, 2006; this date does not establish years in practice.
-
Published CMS data list 3,390 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 1,606 service units.
- J3301 — Injection, triamcinolone acetonide, not otherwise specified, 10 mg: 934 service units.
- 93000 — Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report: 418 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 11 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 13,389 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Losartan Potassium — 629 prescription fills, including refills.
- Atorvastatin Calcium — 593 prescription fills, including refills.
- Metformin Hcl — 463 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 192 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Internal Medicine in Encino, CA (2024, 26 clinicians with data). Median for this group: 4,033. Middle half: 1,036 to 8,325.
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in California (2024, 8,005 clinicians with data). Median for this group: 547. Middle half: 197 to 1,242.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 8,470 in 2020 to 3,390 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
16661 Ventura Blvd Ste 815
Encino, CA 914361996
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
2000
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
166 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $256,871 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $199,289 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
16,365 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,847,136 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $23,559.37 across 713 records.
By nature of payment (3 largest of 4)
- Food and Beverage: $18,262.04 across 709 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $4,800.00 across 2 records.
- Travel and Lodging: $496.13 across 1 record.
Reporting-company totals (3 largest of 35)
- Amgen Inc.: $7,167.22 across 81 records.
- Aimmune Therapeutics, Inc.: $1,264.05 across 51 records.
- Mannkind Corporation: $1,236.93 across 25 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
26 years (graduated 2000)
CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Javaherian has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Javaherian as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Encino and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Internal Medicine in Encino, CA (2024, 26 clinicians with data). Median for this group: 4,033. Middle half: 1,036 to 8,325.
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in California (2024, 8,005 clinicians with data). Median for this group: 547. Middle half: 197 to 1,242.
Medicare-allowed amount
Close to the middle for clinicians listed under Internal Medicine in Encino, CA (2024, 26 clinicians with data). Median for this group: $264,829. Middle half: $87,362 to $504,596.
A higher Medicare-allowed amount than 90% of clinicians listed under Internal Medicine in California (2024, 8,005 clinicians with data). Median for this group: $57,391. Middle half: $20,415 to $125,751.
Paid by Medicare
Close to the middle for clinicians listed under Internal Medicine in Encino, CA (2024, 26 clinicians with data). Median for this group: $206,568. Middle half: $63,360 to $384,348.
A higher Medicare payment amount than 90% of clinicians listed under Internal Medicine in California (2024, 8,005 clinicians with data). Median for this group: $43,431. Middle half: $14,887 to $95,905.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Internal Medicine in Encino, CA (2024, 31 clinicians with data). Median for this group: 1,918. Middle half: 813 to 6,299.
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in California (2024, 10,795 clinicians with data). Median for this group: 1,254. Middle half: 150 to 4,240.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine in Encino, CA (2024, 31 clinicians with data). Median for this group: $183,456. Middle half: $34,471 to $1,433,795.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in California (2024, 10,795 clinicians with data). Median for this group: $88,105. Middle half: $7,557 to $307,080.
44 active clinicians are listed under Internal Medicine with a practice address in Encino, CA (17,717 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Encino
34.1% of these 44 clinicians have the CMS telehealth indicator.
63.6% of these 44 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 60% from 8,470 in 2020 to 3,390 in 2024.
- 2020: 8,470
- 2021: 8,797
- 2022: 5,606
- 2023: 2,923
- 2024: 3,390
-
Medicare-allowed amount
Medicare-allowed amount decreased 29% from $361,503 in 2020 to $256,871 in 2024.
- 2020: $361,503
- 2021: $398,938
- 2022: $297,466
- 2023: $231,658
- 2024: $256,871
-
Paid by Medicare
Paid by Medicare decreased 30% from $283,857 in 2020 to $199,289 in 2024.
- 2020: $283,857
- 2021: $312,326
- 2022: $231,799
- 2023: $178,200
- 2024: $199,289
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 12,371 in 2020 and 13,389 in 2024.
- 2020: 12,371
- 2021: 14,794
- 2022: 15,644
- 2023: 13,499
- 2024: 13,389
-
30-day fills
30-day fills decreased 19% from 20,140 in 2020 to 16,365 in 2024.
- 2020: 20,140
- 2021: 20,073
- 2022: 19,389
- 2023: 16,953
- 2024: 16,365
-
Part D drug cost
Part D drug cost decreased 29% from $4,035,555 in 2020 to $2,847,136 in 2024.
- 2020: $4,035,555
- 2021: $4,390,453
- 2022: $4,778,896
- 2023: $3,870,170
- 2024: $2,847,136
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 56% from $53,873.56 in 2021 to $23,559.37 in 2025.
- 2021: $53,873.56
- 2022: $61,527.24
- 2023: $30,240.57
- 2024: $25,122.91
- 2025: $23,559.37
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 713 records totaling $23,559.37.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
REPATHA | General | $2,400.00 |
| Amgen Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
REPATHA | General | $2,400.00 |
| Amgen Inc. |
Travel and Lodging
In-kind items and services
|
REPATHA | General | $496.13 |
| Mannkind Corporation |
Food and Beverage
In-kind items and services
|
AFREZZA | General | $148.82 |
| Mannkind Corporation |
Food and Beverage
In-kind items and services
|
AFREZZA | General | $148.36 |
| Mannkind Corporation |
Food and Beverage
In-kind items and services
|
AFREZZA | General | $142.78 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEPEZZA | General | $142.73 |
| Mannkind Corporation |
Food and Beverage
In-kind items and services
|
AFREZZA | General | $140.27 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
FANAPT | General | $124.96 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
QULIPTA | General | $123.96 |
| Vanda Pharmaceuticals Inc. |
Food and Beverage
Cash or cash equivalent
|
FANAPT | General | $123.30 |
| Mannkind Corporation |
Food and Beverage
In-kind items and services
|
AFREZZA | General | $105.46 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEPEZZA | General | $39.36 |
| Neurocrine BioSciences, Inc. |
Food and Beverage
In-kind items and services
|
INGREZZA | General | $38.06 |
| Kowa Pharmaceuticals America, Inc. |
Food and Beverage
In-kind items and services
|
ZORYVE | General | $35.28 |
| Radius Health, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $34.88 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $33.69 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Symbravo | General | $33.51 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Veozah | General | $33.32 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Symbravo | General | $33.30 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Symbravo | General | $33.29 |
| Radius Health, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $33.28 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $33.26 |
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Symbravo | General | $33.25 |
| Aimmune Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
ZENPEP | General | $33.20 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
1,606 | 164 | $188.35 | $138.32 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
934 | 89 | $20.00 | $0.97 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
418 | 130 | $46.12 | $15.59 |
|
20610
Aspiration and/or injection of fluid from large joint
|
152 | 87 | $105.00 | $70.41 |
|
69210
Removal of impacted ear wax
|
109 | 76 | $65.00 | $51.87 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
45 | 35 | $145.22 | $98.29 |
|
G0008
Administration of influenza virus vaccine
|
41 | 38 | $45.00 | $35.02 |
|
90658
Influenza vaccine, trivalent, 0.5 ml dosage
|
39 | 38 | $70.00 | $21.42 |
|
82962
Blood glucose (sugar) test performed by hand-held instrument
|
19 | 16 | $10.00 | $3.21 |
|
96372
Injection of drug or substance under skin or into muscle
|
14 | 11 | $50.00 | $15.76 |
|
99496
Transitional care management services for problem of high complexity
|
13 | 13 | $350.00 | $305.69 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Losartan Potassium | Losartan Potassium | 629 | 26,968 | $2,731.01 | 107 |
| Atorvastatin Calcium | Atorvastatin Calcium | 593 | 27,010 | $3,196.45 | 110 |
| Metformin Hcl | Metformin Hcl | 463 | 19,909 | $1,794.48 | 82 |
| Vascepa | Icosapent Ethyl | 425 | 13,560 | $150,487.14 | 64 |
| Omeprazole | Omeprazole | 374 | 15,100 | $2,406.13 | 69 |
| Amlodipine Besylate | Amlodipine Besylate | 355 | 15,480 | $1,237.47 | 67 |
| Levothyroxine Sodium | Levothyroxine Sodium | 349 | 14,977 | $2,336.65 | 53 |
| Allopurinol | Allopurinol | 247 | 8,010 | $1,099.71 | 35 |
| Donepezil Hcl | Donepezil Hcl | 244 | 8,248 | $1,027.21 | 33 |
| Icosapent Ethyl | Icosapent Ethyl | 238 | 7,335 | $32,522.72 | 45 |
| Gabapentin | Gabapentin | 233 | 7,753 | $1,895.94 | 43 |
| Benazepril Hcl | Benazepril Hcl | 232 | 10,290 | $1,339.03 | 39 |
| Nexlizet | Bempedoic Acid/Ezetimibe | 226 | 7,140 | $95,959.98 | 48 |
| Tramadol Hcl | Tramadol Hcl | 192 | 4,324 | $704.01 | 46 |
| Repatha Sureclick | Evolocumab | 189 | 5,422 | $103,985.78 | 43 |
| Ozempic | Semaglutide | 188 | 6,000 | $176,951.58 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 185 | 7,950 | $1,406.58 | 36 |
| Lisinopril | Lisinopril | 184 | 7,620 | $717.91 | 30 |
| Diclofenac Sodium | Diclofenac Sodium | 178 | 5,654 | $10,351.01 | 41 |
| Jardiance | Empagliflozin | 177 | 5,490 | $106,270.67 | 25 |
| Januvia | Sitagliptin Phosphate | 160 | 5,220 | $93,934.73 | 26 |
| Meclizine Hcl | Meclizine Hcl | 152 | 4,198 | $1,135.01 | 26 |
| Kerendia | Finerenone | 152 | 4,950 | $104,054.76 | 36 |
| Furosemide | Furosemide | 151 | 4,920 | $399.12 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 149 | 6,390 | $1,594.86 | 24 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20050921001057
CA
6103850953
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dentist
Doctor of Dental Surgery
Career & Practice History
NPI enumerated June 16, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Encino
- Dr. Keyvan Shirazi, MD
- Dr. David Zarian, MD
- Dr. Victoria Borovsky, MD
- Tom Chen
- Dr. Isaac Adatto, MD
- Dr. Faraaz Osmani, MD
Mailing Address
16661 Ventura Blvd Ste 815
Encino, CA 914361996
Phone: 8185013366